A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- RANDOMIZED · PARALLEL · HEALTH SERVICES RESEARCH · DOUBLE
- Evidence population
- Human clinical study registration
- Participants
- 400
- Population
- ALL · 40 Years to 60 Years
- Duration
- 2024-09-23 to 2025-06-30
- Intervention
- Multivitamin/Mineral supplements; Placebo
- Comparator
- Placebo
- Outcomes measured
- Change in blood DNA methylation status, years — Baseline, 6 months and 12 months; Body Mass Index (BMI) change — Baseline, 6 months and 12 months; Waist-to-hip ratio change — Baseline, 6 months and 12 months; Body fat mass (kg) change — Baseline, 6 months and 12 months; Skeletal muscle mass (kg) change — Baseline, 6 months and 12 months; Percentage body fat (%) change — Baseline, 6 months and 12 months; Systolic blood pressure (mm Hg) change — Baseline, 6 months and 12 months; Diastolic blood pressure (mm Hg) change — Baseline, 6 months and 12 months; Pulse rate (BPM) change — Baseline, 6 months and 12 months; Skin elasticity (mm/time) change — Baseline, 6 months and 12 months; Skin colour (L* a* b*) change — Baseline, 6 months and 12 months; Skin autofluorescence (au) change — Baseline, 6 months and 12 months; Complete blood count — Baseline, 6 months and 12 months; Change in immune parameters: complete blood count — Baseline, 6 months and 12 months; Change in immune parameters: inflammatory parameters in serum (mg/dL) — Baseline, 6 months, 12 months; Change in clinical blood parameters: renal function (mg/dL) — Baseline, 6 months and 12 months; Change in clinical blood parameters: lipid profile test (mmol/L) — Baseline, 6 months and 12 months; Change in clinical blood parameters: glucose (mg/dL) — Baseline, 6 months and 12 months; Change in clinical blood parameters: insulin (mg/dL) — Baseline, 6 months and 12 months; Change in clinical blood parameters: glycelated haemoglobin, HbA1C (mmol/mol) — Baseline, 6 months and 12 months
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Biological age biomarkers · 100%Title contains controlled term: biological age. Abstract contains controlled term: biological age. Title supplies longevity context: biological age. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.